Gevo, Inc.
NASDAQ:GEVOChemicals - Specialty
+$0.04 today
- Market cap
- $420.54M
- Beta
- 0.99
- P/E (TTM)
- -10.7
- EPS (TTM)
- -$0.14
Volume 2.74M
Average 3.88M
GEVO Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Gevo, Inc.NASDAQ: GEVO
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of $8.88M (cash outflow) rose 52.1% year over year, ahead of the -16.2% change in trailing-twelve-month capital expenditures. Sequentially, it fell 19.9% from the prior quarter. Over 3 fiscal years it compounded at -29.0% a year.
Context
- Capital expenditures amounted to 18.8% of revenue in FY2025, down 283.3 pp from a year earlier.
- Capital expenditures grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +52.1% holds above the trailing-twelve-month pace of -16.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (30.11M) USD
- Year-over-year change
- +41.1%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (30.11M) | +41.1% |
| FY2024 | 2024-12-31 | (51.09M) | +6.2% |
| FY2023 | 2023-12-31 | (54.46M) | +35.2% |
| FY2022 | 2022-12-31 | (84.09M) | -27.5% |
| FY2021 | 2021-12-31 | (65.94M) | — |
Capital Expenditures vs competitors
How GEVO compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -16.2% is the 6th highest of 11, against a peer median of -15.5%.
- Capital expenditures amounts to 18.9% of revenue for GEVO, versus a peer median of 5.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $298M USD | -26.2% | -90.7% | 10.2% | |
| LTM Mar 2026 | $118.32M USD | -10.6% | +9.2% | 7.6% | |
| LTM Mar 2026 | $52.1M USD | -20.3% | -19.5% | 2.8% | |
| LTM Mar 2026 | $41.1M USD | +11.7% | -12.1% | 2.2% | |
| LTM Mar 2026 | $34.5M USD | -39.8% | -12.4% | 1.7% | |
| LTM Mar 2026 | $33.03M USD | -16.2% | -29.0% | 18.9% | |
| LTM Mar 2026 | $26.94M USD | -70.1% | -44.0% | 1.4% | |
| LTM Mar 2026 | CA$7.58M CAD | +50.3% | -31.7% | 48.3% | |
ADURAduro Clean Technologies Inc. | LTM Feb 2026 | CA$5.34M CAD | +653.9% | +51.9% | 2207.3% |
| LTM Mar 2026 | $3.89M USD | +104.1% | +19.1% | 0.6% | |
| LTM Mar 2026 | $882.81K USD | -68.1% | -5.3% | 363.1% | |
| Peer median (excluding GEVO) | — | -15.5% | -12.3% | 5.2% | |
Competitors are the stored peer set for GEVO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (59.2M) | (98.01M) | (66.22M) | (78.64M) | (32.63M) |
| Depreciation & Amortization | 5.13M | 7.89M | 19.01M | 18.3M | 27.34M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | (52.03M) |
| Stock-Based Compensation | 9.87M | 17.42M | 17.09M | 14.73M | 9.21M |
| Change in Working Capital | (13.68M) | (458K) | (24.4M) | (14.27M) | 34.76M |
| Accounts Receivables | (257K) | 502K | (2.15M) | 417K | (1.01M) |
| Inventory | (259K) | (2M) | 670K | (706K) | (4.06M) |
| Accounts Payables | (271K) | 3.64M | 0 | 0 | 5.28M |
| Other Working Capital | (12.9M) | (2.59M) | (22.93M) | (13.98M) | 34.56M |
| Other Non-Cash Items | 9.61M | 28.85M | 806K | 2.5M | (57K) |
| Operating Cash Flow | (48.27M) | (44.31M) | (53.72M) | (57.38M) | (13.4M) |
| Capital Expenditures | (65.94M) | (84.09M) | (54.46M) | (51.09M) | (30.11M) |
| Acquisitions (Net) | 0 | 0 | 0 | (6.07M) | (191.46M) |
| Purchases of Investments | (424.99M) | (130.4M) | 0 | 0 | 0 |
| Sales of Investments | 79.57M | 299.58M | 168.55M | 0 | 0 |
| Other Investing Activities | (9.17M) | (10K) | 34K | 5.34M | 0 |
| Investing Cash Flow | (411.36M) | 85.09M | 114.13M | (51.82M) | (221.57M) |
| Debt Repayment | 68.83M | (162K) | (189K) | (1.04M) | 93.54M |
| Common Stock Issued | 489.37M | 150M | 0 | 0 | 798K |
| Common Stock Repurchased | 0 | 0 | 0 | (4.71M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (40.88M) | (11.28M) | 0 | (1.62M) | (1.45M) |
| Financing Cash Flow | 517.32M | 138.56M | (189K) | (7.36M) | 92.88M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 61.15M |
| Net Change in Cash | 57.7M | 179.34M | 60.22M | (116.56M) | (80.95M) |
| Free Cash Flow | (114.21M) | (128.4M) | (108.17M) | (108.47M) | (43.51M) |
Gevo, Inc.
NASDAQ:GEVO
Intrinsic Alpha fair value
Locked
Current Price
$1.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.